69
Participants
Start Date
February 20, 2018
Primary Completion Date
August 4, 2022
Study Completion Date
August 4, 2022
KZR-616
Subcutaneous Injection of KZR-616
The Royal Melbourne Hospital, Parkville
Monash Health, Clayton
NYU Langone Orthopedic Center - Seligman Center for Advanced Therapeutics, New York
Northwell Health, Great Neck
Centro de Investigación Clínica Trujillo E.I.R.L/ Clínica Peruano Americana S.A., Trujillo
Instituto Nacional de Cardiología Ignacio Chavez, Mexico City
"Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran", Mexico City
University of Rochester Medical Center, Rochester
Investigaciones Clinicas SAC, Lima
Unidad de Investigacion en Reumatologia e Inmunologia Clinica San Juan Bautista, Lima
SC Nephrology & Hypertension Center, Inc., Orangeburg
Omega Research Maitland, Orlando
SouthCoast Research Center, Inc., Miami
Hope Clinical Trials, Inc., Miami
Advent Health Medical Group, Tampa
Arthritis Center, Inc, Palm Harbor
Ramesh C. Gupta, MD, Memphis
The Ohio State University Wexner Medical Center, Columbus
Centro Integral de Reumatologia SA de CV, Guadalajara
University of Iowa, Iowa City
Hospital Universitario Dr José Eleuterio Gonzalez, Monterrey
Accurate Clinical Research, Inc., Houston
Accurate Clinical Management, LLC, Houston
MedResearch, Inc., El Paso
Inland Rheumatology Clinical Trials, Inc., Upland
Tolyatti City Clinical Hospital #1, Tolyatti
Kuzbass Clinical Hospital, Kemerovo
Medical Center Revma-Med, Kemerovo
Medicity SAS, Santander
Servimed S.A.S., Bucaramanga
Academic Medical Research Institute, Los Angeles
Centro Integral de Reumatologia de Caribe CIRCARIBE S.A.S, Barranquilla
Clinica de la Costa, Barranquilla
Clinica de Artritis Temprana, Santiago de Cali
Bioclinica, Lodz
Harmoniya Krasy, Kyiv
Lead Sponsor
Kezar Life Sciences, Inc.
INDUSTRY